MaxCyte, Inc.
MXCT
$1.27
$0.032.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.27M | 9.65M | 7.30M | 6.83M | 8.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.27M | 9.65M | 7.30M | 6.83M | 8.51M |
| Cost of Revenue | 1.68M | 1.57M | 1.61M | 1.60M | 1.52M |
| Gross Profit | 5.60M | 8.08M | 5.69M | 5.23M | 6.99M |
| SG&A Expenses | 10.62M | 9.39M | 8.24M | 9.96M | 13.87M |
| Depreciation & Amortization | 953.00K | 1.02M | 1.04M | 1.04M | 1.08M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.50M | 15.84M | 14.22M | 17.92M | 22.73M |
| Operating Income | -10.23M | -6.19M | -6.92M | -11.09M | -14.23M |
| Income Before Tax | -8.87M | -4.75M | -9.60M | -12.42M | -12.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.87M | -4.75M | -9.60M | -12.42M | -12.36M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.87M | -4.75M | -9.60M | -12.42M | -12.36M |
| EBIT | -10.23M | -6.19M | -6.92M | -11.09M | -14.23M |
| EBITDA | -9.25M | -5.14M | -5.86M | -10.03M | -13.13M |
| EPS Basic | -0.08 | -0.04 | -0.09 | -0.12 | -0.12 |
| Normalized Basic EPS | -0.05 | -0.03 | -0.03 | -0.05 | -0.07 |
| EPS Diluted | -0.08 | -0.04 | -0.09 | -0.12 | -0.12 |
| Normalized Diluted EPS | -0.05 | -0.03 | -0.03 | -0.05 | -0.07 |
| Average Basic Shares Outstanding | 106.82M | 106.88M | 106.73M | 106.61M | 106.40M |
| Average Diluted Shares Outstanding | 106.82M | 106.88M | 106.73M | 106.61M | 106.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |